Nevertheless, given that METTL3 and YTHDF1 are significantly associated with prognosis of HCC patients, elucidating the mechanisms of m6A in HCC chemoresistance is of great importance for the treatment of drug resistance in HCC. This evidence concerns the gene METTL3 and hepatocellular carcinoma.